Emendo Biotherapeutics

1 follower


Emendo biotherapeutics develops next-generation gene-editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.

Industries

Headquarters

Stage

Employees

Links

Org chart

Todd Wider
Chairman & Chief Medical Officer
Rachel Diamant
Chief Business Officer
Liat Zadikov
EVP, Human Resources
Roy Sirkis
VP, Biomaterials Development & Production
Ella Segal
Head, Analytics
Dana Sella
QA Project Manager
Idit Buch
VP, Computational Biology
Ira Gotliv (Lubarski)
VP, Preclinical Research
Mushka Herzel
Financial Controller